---
title: "Lily & Beauty: Net loss of 18.322 million yuan in the first quarter of 2025"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237816656.md"
description: "Lily & Beauty announced that its revenue for the first quarter of 2025 was 361 million yuan, a year-on-year decrease of 23.58%; the net loss was 18.322 million yuan, compared to a net loss of 9.5461 million yuan in the same period last year"
datetime: "2025-04-28T10:07:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237816656.md)
  - [en](https://longbridge.com/en/news/237816656.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237816656.md)
generator: "portal-rs"
---

# Lily & Beauty: Net loss of 18.322 million yuan in the first quarter of 2025

Lily & Beauty announced that its revenue for the first quarter of 2025 was 361 million yuan, a year-on-year decrease of 23.58%; the net loss was 18.322 million yuan, compared to a net loss of 9.5461 million yuan in the same period last year

### Related Stocks

- [605136.CN](https://longbridge.com/en/quote/605136.CN.md)

## Related News & Research

- [China Internet Investment Fund targets deep-sea, low-altitude embodied intelligence applications, chair says](https://longbridge.com/en/news/298032703.md)
- [Trump's latest threat - to stop trading with some countries unless there's a rate cut - risks shock to U.S. economy](https://longbridge.com/en/news/298067979.md)
- [Sephora plans exclusive drops for TikTok Shop](https://longbridge.com/en/news/298074068.md)
- [21:30 ETRoborock Redefines Human-Centered Cleaning at IFA 2026: Unveiling a Comprehensive Ecosystem from the Living Room to the Pool](https://longbridge.com/en/news/297975442.md)
- [Fosun Pharma subsidiary Shanghai Fosun Pharmaceutical Industrial Development wins China approval for new Luvometinib use in adult NF1 tumors](https://longbridge.com/en/news/297890174.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**